実績

診療実績

照射開始日ベース／暦年半期（上半期=1–6月、下半期=7–12月）

学術活動

英文誌

Ajithkumar T, Avanzo M, Fuji H, et al. PENTEC Organ-Specific Report: Brain and Brain Stem Necrosis After Reirradiation for Recurrent Childhood Primary Central Nervous System Tumors: A PENTEC Comprehensive Review. Int J Radiat Oncol Biol Phys, 2024, doi.org/10.1016/j.ijrobp.2023.12.043.

Yamamoto Y, Aoki A, Fuji H, Chen G, Bolt T, Suto M, Mori R, Uchida K, Takehara K, Gai R. Parents' preferences for respite care of children with medical complexity. Pediatr Int. 2023 ;65(1):e15703. doi: 10.1111/ped.15703..

Fuji H, Fujibuchi T, Tanaka H, Ogawa Y, Noda C, Hayakawa M, Nakamura K, Tanaka K. Changes in satisfaction and anxiety about radiotherapy for pediatric cancer by two-step audio-visual instruction. Tech Innov Patient Support Radiat Oncol. 2023,10;27:100214. doi: 10.1016/j.tipsro.2023.100214.

Hong KT, Han JW, Fuji H, Byun HK, et al. Outcomes of intracranial non-germinomatous germ cell tumors: a retrospective Asian multinational study on treatment strategies and prognostic factors. J Neurooncol. 2022;160(1):41-53. doi: 10.1007/s11060-022-04100-w.

Mizumoto M, Fuji H, Miyachi M, Soejima T, Yamamoto T, Aibe N, Demizu Y, Iwata H, Hashimoto T, Motegi A, Kawamura A, Terashima K, Fukushima T, Nakao T, Takada, Sumioae M, Oshima J, Moriwaki K, Sakurai H: Proton beam therapy for children and adolescents and young adults (AYAs): JASTRO and JSPHO Guidelines. Cancer Treat Rev. 2021;98:102209.

Hishiki T, Fuji H, Kanamori Y, et al. Definitive Tumor Resection after Myeloablative High Dose Chemotherapy Is a Feasible and Effective Option in the Multimodal Treatment of High-Risk Neuroblastoma: A Single Institution Experience. Journal of Pediatric Surgery 2020;55:1655-1659

Hiyama E, Fuji H, Yoshimura K, et al. Outcome and Late Complications of Hepatoblastomas Treated Using the Japanese Study Group for Pediatric Liver Tumor 2 Protocol. Journal of Clinical Oncology 2020;38:2488-2498

Nakajima Y, Kadoya N, Kanai T, Saito M, Kito S, Hashimoto S, et al. Evaluation of the effect of user-guided deformable image registration of thoracic images on registration accuracy among users. Med Dosim. 2020;45(3):206-212.

Hashimoto S, Nakajima Y, Kadoya N, Abe K, Karasawa K. Energy dependence of a radiophotoluminescent glass dosimeter for HDR ¹⁹²Ir brachytherapy source. Med Phys. 2019 Feb;46(2):964-972.

Abe K, Kadoya N, Sato S, Hashimoto S, et al. Impact of a commercially available model-based dose calculation algorithm on treatment planning of high-dose-rate brachytherapy in patients with cervical cancer. J Radiat Res. 2018 Mar 1;59(2):198-206.

Hashimoto S, Fujita Y, Katayose T, Mizuno H, Saitoh H, Karasawa K. Field-size correction factors of a radiophotoluminescent glass dosimeter for small-field and intensity-modulated radiation therapy beams. Med Phys. 2018 Jan;45(1):382-390.

Katayose T, Saitoh H, Igari M, Chang W, Hashimoto S, Morioka M. Changes in deviation of absorbed dose to water among users by chamber calibration shift. Jpn J Radiol. 2017 Jul;35(7):389-397.

Shikama N, Kumazaki Y, Miyazawa K, Nihei K, Hashimoto S, Tsukamoto N. Rectal Toxicity After Extremely Hypofractionated Radiotherapy Using a Non-Isocentric Robotic Radiosurgery System for Early Stage Prostate Cancer. World J Oncol. 2016 Dec;7(5-6):98-103

Miyashita H, Hatanaka S, Fujita Y, Hashimoto S, et al. Quantitative analysis of in-air output ratio. J Radiat Res. 2013 May;54(3):553-60.

Hashimoto S, Karasawa K, Fujita Y, et al. Evaluation of beam hardening and photon scatter by brass compensator for IMRT. J Radiat Res. 2012 Nov 1;53(6):999-1005.

書籍

• 藤　浩（共著）.　がん・放射線療法　改訂第8版, Gakken 2023:1286-1288
• 藤　浩（共著）.　放射線治療計画ガイドライン 2020年版, 金原出版　2020；355-362
• 藤　浩（共著）.　小児・AYA世代の腫瘍に対する陽子線治療診療ガイドライン　2019年版, 金原出版　2019；38-43
• 橋本　慎平（共著）.　The SBRT book　篠原出版新社　2016　234-245
• 橋本　慎平（共著）.　詳説放射線治療の精度管理と測定技術 : 高精度放射線治療に対応した実践Q&A　中外医学社　2012：84-86, 92-94, 204-208
• 橋本　慎平（共著）.　詳説強度変調放射線治療 : 物理・技術的ガイドラインの詳細　中外医学社　2010：155-157